# Single-cell transcriptomic analysis reveals intra-tumoral heterogeneity and immunotherapy strategies in high-grade serous ovarian cancer

**Authors:** Chunhui Gao, Xiaogang Lv, Anqi Pan, Lipai Chen, Qianqian Liu, Donghui Zhang, Wenjuan Wu

PMC · DOI: 10.1016/j.isci.2026.115266 · 2026-03-06

## TL;DR

This study uses single-cell RNA sequencing to uncover cell diversity in ovarian cancer and identifies immune-related cell types linked to better patient outcomes.

## Contribution

The study reveals how IFIT1+ epithelial cells enhance immune response and identifies potential biomarkers for HGSOC treatment.

## Key findings

- Seven major cell types were identified in high-grade serous ovarian cancer.
- IFIT1+ epithelial cells overexpressing MHC class I are associated with improved patient prognosis.
- Tumor-associated fibroblasts and epithelial cells contribute to chemoresistance and metastasis.

## Abstract

High-grade serous ovarian cancer (HGSOC) is the most common type of ovarian cancer, characterized by high intra-tumoral heterogeneity and platinum resistance. In this study, single-cell RNA sequencing data with HGSOC were analyzed. We identified seven major cell types in HGSOC and observed significant changes in the proportions of cancer-associated fibroblasts and epithelial cells as tumor drug resistance increased. The abundance of IFIT1+ and CXCL10+ epithelial cells highly expressing MHC class Ⅰ molecules, which are strongly associated with antigen processing and presentation, was found to improve patients’ outcomes. Ultimately, the relationships between IFIT1, MHC class Ⅰ molecules, and CD8+ T cells were verified in additional cohorts, using multiplex immunohistochemistry. Our data suggest that IFIT1+ epithelial cells might enhance immune surveillance via increasing the expression of MHC class Ⅰ molecules and activating CD8+ T cells. Our findings provide a valuable resource for deciphering intra-tumoral heterogeneity and mechanisms driving the aggressiveness of HGSOC, revealing potential biomarkers for anti-cancer treatment.

•A single-cell RNA-seq atlas reveals extensive intra-tumoral heterogeneity in HGSOC•Tumor-associated fibroblasts and epithelial cells promote chemoresistance and metastasis•IFIT1+ epithelial cells overexpressing MHC class Ⅰ are associated with good prognosis

A single-cell RNA-seq atlas reveals extensive intra-tumoral heterogeneity in HGSOC

Tumor-associated fibroblasts and epithelial cells promote chemoresistance and metastasis

IFIT1+ epithelial cells overexpressing MHC class Ⅰ are associated with good prognosis

Cancer; Microenvironment; Transcriptomics

## Linked entities

- **Genes:** IFIT1 (interferon induced protein with tetratricopeptide repeats 1) [NCBI Gene 3434]
- **Diseases:** ovarian cancer (MONDO:0005140)

## Full-text entities

- **Genes:** CD8A (CD8 subunit alpha) [NCBI Gene 925] {aka CD8, CD8alpha, IMD116, Leu2, p32}, IFIT1 (interferon induced protein with tetratricopeptide repeats 1) [NCBI Gene 3434] {aka C56, G10P1, IFI-56, IFI-56K, IFI56, IFIT-1}, CXCL10 (C-X-C motif chemokine ligand 10) [NCBI Gene 3627] {aka C7, IFI10, INP10, IP-10, SCYB10, crg-2}
- **Diseases:** cancer (MESH:D009369), HGSOC (MESH:D010051)
- **Chemicals:** platinum (MESH:D010984)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Figures

9 figures with captions in the complete paper: https://tomesphere.com/paper/PMC13018870/full.md

---
Source: https://tomesphere.com/paper/PMC13018870